Concepedia

Chava Perry

CP

Statistics

Publications

4

Citations

246

H-Index

4

Active since

2007

Affiliations

Tel Aviv Sourasky Medical Center(Current)

Tel Aviv University

Hadassah Academic College

Chava Perry is an author at Tel Aviv Sourasky Medical Center specializing in oncology, non-hodgkin lymphoma treatment, and medicine.

Publications per year

2007–2021

4

Publications

4

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

Chava Perry, Efrat Luttwak, R. Balaban et al. · Blood Advances · 2021 · 170 citations · Full text

, , +13

Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience

Yafit Segman, Elena Ribakovsky, Abraham Avigdor et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 36 citations

, , +16

Early‐mid treatment C‐reactive protein level is a prognostic factor in aggressive non‐Hodgkin’s lymphoma

Yair Herishanu, Chava Perry, Rony Braunstein et al. · European Journal Of Haematology · 2007 · 26 citations

, , +12

Reduced-dose ICE chemotherapy ± rituximab is a safe and effective salvage therapy for fit elderly patients with diffuse large B-cell lymphoma

Nadav Sarid, Erel Joffe, Lili Gibstein et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 14 citations

, , +13

1–4 of 4